TRIM33 and cancer: Evidence pertaining to effective cancer screening is limited but indicates the utility of CT scanning of the thorax, abdomen, and pelvis for at-risk patients, such as anti-transcriptional intermediary factor-1γ (anti-TIF1-γ) positive patients.